I n this issue of Cancer Cytopathology, Abati et al. 1 , using the cellular material in fine-needle aspiration (FNA) biopsies, demonstrate the feasibility of detecting loss of heterozygosity (LOH) at the p53 locus on chromosome 17, the putative neuroblastoma tumor suppressor locus on chromosome 1, a
Loss of heterozygosity analysis to diagnose adrenal cortical carcinoma
β Scribed by Abati, Andrea ;Merino, Maria
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 40 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Reprints are not available.
π SIMILAR VOLUMES
We have previously observed loss of heterozygosity (LOH) at a single locus (del-27) on human chromosome 5p13-12 to correlate with bladder tumor progression. In this study, we examined 33 bladder tumors for their pattern of allelic loss on chromosome 5p using 7 microsatellite markers. In 14 of 15 bla
Previous reports have suggested that heterozygotes for ataxia-telangiectasia (A-T) have an increased risk of cancer, in particular breast cancer. The ATM gene, responsible for A-T, was recently cloned. Loss of heterozygosity (LOH) in the chromosome band 11q23, where the ATM gene is located, has been
Neoplastic development is a multistep process that involves the stochastic accumulation of heritable genetic alterations in proto-oncogenes, DNA repair genes, and tumor suppressor genes. Loss of heterozygosity (LOH) analysis has been used successfully to identify the genetic determinants of neoplast
Multiple renal cell tumours from three unrelated patients have been analysed for loss of heterozygosity of 3p, mutation of VHL, and chromosome 7 and 17 imbalances. Loss of 3p alleles is characteristic for clear cell type tumours and the combination of 17, 117 for chromophilic cell type tumours. Thus